NCT01064089View on ClinicalTrials.gov

Dose Escalation of HSP990 in Japan/Korea

PHASE1TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

HSP990

Trial Locations (2)

466-8560

Novartis Investigative Site, Nagoya

277-8577

Novartis Investigative Site, Kashiwa

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY